WINTON GROUP Ltd reduced its stake in Hologic, Inc. (NASDAQ:HOLX) by 75.9% in the 4th quarter, Holdings Channel reports. The firm owned 8,359 shares of the medical equipment provider’s stock after selling 26,271 shares during the period. WINTON GROUP Ltd’s holdings in Hologic were worth $357,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Chevy Chase Trust Holdings Inc. increased its position in Hologic by 1.4% in the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 244,620 shares of the medical equipment provider’s stock worth $8,975,000 after buying an additional 3,391 shares during the period. Janus Henderson Group PLC increased its position in Hologic by 15.5% in the 3rd quarter. Janus Henderson Group PLC now owns 285,035 shares of the medical equipment provider’s stock worth $10,458,000 after buying an additional 38,283 shares during the period. Cipher Capital LP increased its position in Hologic by 57.9% in the 3rd quarter. Cipher Capital LP now owns 117,673 shares of the medical equipment provider’s stock worth $4,317,000 after buying an additional 43,146 shares during the period. Fiduciary Trust Co. bought a new position in Hologic in the 4th quarter worth approximately $208,000. Finally, Ladenburg Thalmann Financial Services Inc. increased its position in Hologic by 66.4% in the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 12,487 shares of the medical equipment provider’s stock worth $458,000 after buying an additional 4,984 shares during the period. 97.59% of the stock is currently owned by institutional investors.
In related news, Director Namal Nawana purchased 6,600 shares of the stock in a transaction on Tuesday, February 13th. The shares were purchased at an average cost of $37.88 per share, for a total transaction of $250,008.00. Following the completion of the transaction, the director now directly owns 6,954 shares of the company’s stock, valued at approximately $263,417.52. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.88% of the company’s stock.
Shares of Hologic, Inc. (NASDAQ HOLX) opened at $38.78 on Wednesday. The stock has a market capitalization of $10,765.28, a P/E ratio of 18.99, a PEG ratio of 1.76 and a beta of 0.84. The company has a current ratio of 1.25, a quick ratio of 0.98 and a debt-to-equity ratio of 0.87. Hologic, Inc. has a 1 year low of $35.33 and a 1 year high of $46.80.
Hologic (NASDAQ:HOLX) last announced its quarterly earnings results on Thursday, February 8th. The medical equipment provider reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.05. Hologic had a return on equity of 20.07% and a net margin of 34.53%. The firm had revenue of $791.10 million for the quarter, compared to analysts’ expectations of $785.80 million. During the same period in the prior year, the business posted $0.52 earnings per share. The business’s revenue was up 7.7% compared to the same quarter last year. analysts predict that Hologic, Inc. will post 2.25 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This piece was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3261232/winton-group-ltd-has-357000-position-in-hologic-inc-holx.html.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.